Pharma & Biotech Patent Litigation Summit (& UPC Litigation Forum) returns to Amsterdam with 15% IPKat readers’ discount

A stroll along the Amsterdam canals is a must

The Katfriends at Kisaco Research are back with a 3-day conference aimed at patent-focussed IPKat readers. The Pharma & Biotech Patent Litigation Summit will take place in Amsterdam on 21 and 22 January 2025, with the UPC Litigation Forum taking place on 20 January. 

The full event agenda is available here.

According to the organizers, this is Europe’s premier event for patent litigation professionals. Over 450 industry experts are expected to gather for a deep dive deep into the most pressing challenges and innovations in contentious IP law. The latest case law, regulatory updates, and strategic litigation approaches will all be covered, while participants will connect with key stakeholders who drive the future of life sciences IP.

New to this year is the inaugural Diversity & Inclusion in IP workshop during the conference’s UPC Litigation Forum, featuring targeted workshop discussions.

The 2025 edition’s highlights include:

• Latest life science litigation, including cross-border cases, biosimilars, vaccines, and SPCs.
• The UPC’s impact on the life sciences sector, featuring industry-focused panels and a pre-event forum for practical, cross-industry discussions.
• Targeted, in-depth discussions with tracked sessions on MedTech, Large Molecule, and Small Molecule patent litigation.
• Key updates and challenges in divisional patenting, PIs, second medical use, G2/21, and the Bolar exemption from top pharma and biotech IP specialists.
• Judicial perspectives from top UPC technical and legal judges and within the Global Judges Panel session.

IPKat readers are entitled to a 15% discount in the registration fee using VIP code IPKAT_SM at checkout. For further information and to register, click here.